Terbutaline sulfate Tablets Rx
Generic Name and Formulations:
Terbutaline sulfate 2.5mg, 5mg; scored tabs.
Various generic manufacturers
Indications for Terbutaline sulfate Tablets:
Asthma. Chronic bronchitis. Emphysema.
12–15yrs: 2.5mg 3 times daily at 6 hour intervals. >15yrs: 2.5–5mg 3 times daily at 6 hour intervals.
Not for management of preterm labor. Avoid excessive use. Diabetes. Cardiac disease. Hypertension. Hyperthyroidism. Seizure disorders. If subject to hypokalemia, monitor potassium. Pregnancy (Cat.B). Nursing mothers.
Avoid other sympathomimetics (except aerosol bronchodilators), MAOIs, tricyclics. Antagonized by β-blockers.
Tachycardia, palpitations, nervousness, tremor, headache, drowsiness, nausea.
Formerly known under the brand names Brethine, Bricanyl.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Managing Immune-Related Adverse Events
- PD-1/PD-L1 Inhibitors May Increase the Risk of Hyperprogressive Disease in NSCLC
- Predicting Response to Immunotherapy in Late-Stage Melanoma
- Genetic Counseling Recommended for Advanced Prostate Cancer
- A Simplified Dose Schedule of Cetuximab as a Maintenance Therapy in Head and Neck Cancer May Reduce Drug Toxicities
- BRCA1/Shieldin Double Mutations May Signal Resistance to PARP Inhibitors
- Transplant Status May Affect CAR-T Therapy Outcomes in CLL and B-ALL
- Study Zeroes in on Cause of Castration-Resistant Prostate Cancer
- Beyond BRCA: New Predisposition Genes Linked to Breast, Ovarian Cancers
- "Impressive" CNS Responses With Osimertinib Compared With Standard EGFR-TKIs in Patients With CNS Metastases at Baseline